Clinical Trial Update: Psilocybin and Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update involving psilocybin for severe depression, current status and sponsor information provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Helsinki | Conditions: Severe Depression | Phase 2 | Status: UNKNOWN